CONFIDENTIAL MATERIAL OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSIONS. OPTION/LICENSE AGREEMENT THIS AGREEMENT is made by and between Kos Pharmaceuticals, Inc., a corporation of the State of...Option/License Agreement • March 6th, 1997 • Kos Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
10.5 (REFILED) * PLEASE NOTE THAT CERTAIN PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED BASED ON A REQUEST FOR CONFIDENTIAL TREATMENT FILED WITH THE COMMISSION ALONG WITH THE INFORMATION REQUESTED TO BE OMITTED. OPTION & LICENSE AGREEMENT 1. INTRODUCTION...Option & License Agreement • January 14th, 2002 • Biokeys Pharmaceuticals Inc • Pharmaceutical preparations • California
QuickLinks -- Click here to rapidly navigate through this document BETWEEN:Option / License Agreement • October 16th, 2001 • Newtech Resources LTD • British Columbia
KAIZEN FOOD CORPORATION, a corporation incorporated under the laws of the Province of British Columbia, and having an office at Suite 200 - 841 West Broadway, in the City of Vancouver, in the Province of British Columbia, V5Z 1J9
OPTION & LICENSE AGREEMENT USC FILE 2860Option & License Agreement • March 15th, 2007 • Response Genetics Inc • In vitro & in vivo diagnostic substances • California
THIS AGREEMENT is between the UNIVERSITY OF SOUTHERN CALIFORNIA, (hereinafter USC) a California nonprofit corporation with its principal place of business at University Park, Los Angeles, California 90089, and BIOPLAN.COM, INC., a Delaware corporation, with its principal place of business at 405 Lexington Avenue, 23rd Floor, New York, New York 10174 (hereinafter Licensee).
OPTION & LICENSE AGREEMENT by and between INTELLECT NEUROSCIENCES, INC. andOption & License Agreement • February 17th, 2009 • Intellect Neurosciences, Inc. • Pharmaceutical preparations • New York
THIS AGREEMENT is made as of October 3, 2008 (the “Effective Date”) by and between INTELLECT NEUROSCIENCES, INC. having a place of business at 7 West 18th St. 9th Fl. New York 10011 (“Intellect”, and following exercise of the Option (as defined below), “Licensor”), and [***], having a place of business at [***] (“[***]”, and following exercise of the Option, “Licensee”).
ContractOption License Agreement • April 28th, 2017
1 EXHIBIT 10.01A OPTION EXERCISE AND LICENSE AMENDMENT AGREEMENT This OPTION EXERCISE AND LICENSE AMENDMENT AGREEMENT is made and entered into as of the 31st day of March, 1999, by and between the UNIVERSITY OF SOUTHERN CALIFORNIA, a California...Option & License Agreement • December 7th, 2000 • Rubicon Medical Inc
Food Corporation, #200 – 841 West Broadway, Vancouver, B.C., Canada, V5Z 1J9; Ph (604) 739-9772; Fax (604) 739-9782Option/License Agreement • June 3rd, 2002 • Newtech Resources LTD • Pharmaceutical preparations
We have taken a closer look at the Option/License Agreement dated June 30, 2000, between Newtech Resources Ltd. ("Newtech") and Kaizen Food Corporation ("Kaizen"), and have several changes/modifications which we would like to make to the Option/License Agreement.
Institutional Conflict of Interest Management and Monitoring Plan: OmniNano Pharmaceuticals LLCOption & License Agreement • October 31st, 2024
The University of Texas MD Anderson (MD Anderson) and OmniNano Pharmaceuticals LLC (OmniNano) are parties to an Option & License Agreement (Agreement). Under the Agreement, MD Anderson grants a royalty-bearing, exclusive license to certain patent rights pertaining to novel polymeric drug delivery for systemic treatment of pancreatic ductal adenocarcinoma.
1 EXHIBIT 10.1 OPTION & LICENSE AGREEMENT 1. INTRODUCTION THIS AGREEMENT is between the UNIVERSITY OF SOUTHERN CALIFORNIA, (hereinafter USC) a California nonprofit corporation with its principal place of business at University Park, Los Angeles,...Option & License Agreement • December 7th, 2000 • Rubicon Medical Inc • California
